Cargando…
Polypharmacy in a hospitalized psychiatric population: risk estimation and damage quantification
BACKGROUND: Polypharmacy increases the risk of pharmacological interactions, prevalence of secondary effects and with this the lack of adherence to treatment. It is estimated that between 10 and 40% of patients hospitalized in psychiatric institutions are prescribed more than one antipsychotic. The...
Autores principales: | Carmona-Huerta, J., Castiello-de Obeso, S., Ramírez-Palomino, J., Duran-Gutiérrez, R., Cardona-Muller, D., Grover-Paez, F., Fernández-Dorantes, P., Medina-Dávalos, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383213/ https://www.ncbi.nlm.nih.gov/pubmed/30791883 http://dx.doi.org/10.1186/s12888-019-2056-0 |
Ejemplares similares
-
Polypharmacy in psychiatric practice in the Canary Islands
por: De las Cuevas, Carlos, et al.
Publicado: (2004) -
Nationwide study on antipsychotic polypharmacy among forensic psychiatric patients
por: Lassen, Stine, et al.
Publicado: (2023) -
Comprehensive rehabilitation and job reintegration of people with severe mental illness in a Latin American country: REINTEGRA study protocol
por: Carmona-Huerta, Jaime, et al.
Publicado: (2023) -
The Prevalence and Factors Associated With Antipsychotic Polypharmacy in a Forensic Psychiatric Sample
por: Farrell, Christian, et al.
Publicado: (2020) -
Prescription patterns in psychiatric compulsory care: polypharmacy and high-dose antipsychotics
por: Kaikoushi, Katerina, et al.
Publicado: (2021)